Showing 301 - 310 of 550
Persistent link: https://www.econbiz.de/10010283834
We use a public economics framework to consider how pharmaceuticals should be priced when at least some of the R&D incentive comes from sales revenues. We employ familiar techniques of public finance to relax some of the restrictions implied in the standard use of Ramsey pricing. In the more...
Persistent link: https://www.econbiz.de/10005509598
This paper examines the performance small area of welfare estimation. The method combines census and survey data to produce spatially disaggregated poverty and inequality estimates. To test the method, predicted welfare indicators for a set of target populations are compared with their true...
Persistent link: https://www.econbiz.de/10010786978
The rural non-farm sector has traditionally been viewed as a low-productivity sector which produces low quality goods. It is often expected to wither away as a country develops. Recent years have seen a shift away from this position towards recognition that the rural non-farm sector can, and...
Persistent link: https://www.econbiz.de/10011069284
Persistent link: https://www.econbiz.de/10006510962
We explore the substitutability of formal and informal property rights using new survey data from Ecuador, where households have both formal and informal claims to urban residential property. We develop a model of property transactions that distinguishes between transferable and...
Persistent link: https://www.econbiz.de/10005099492
Persistent link: https://www.econbiz.de/10005072758
The authors discuss the use of imputed data in regression analysis, in particular the use of highly disaggregated welfare indicators (from so-called"poverty maps"). They show that such indicators can be used both as explanatory variables on the right-hand side and as the phenomenon to explain on...
Persistent link: https://www.econbiz.de/10005079715
Since the late 1980s the global intellectual property rights (IPR) system has been strengthening dramatically as much of the developing world introduces patent protection for new drug products. This may lead to more research on drugs to address developing country needs. As there are identifiable...
Persistent link: https://www.econbiz.de/10005778178
The decision to require that countries grant product patents for pharmaceutical innovations as a condition of membership in the World Trade Organization was very contentious. Almost 50 developing countries were not granting patent monopolies for drugs during the period the Uruguay round of GATT...
Persistent link: https://www.econbiz.de/10005778771